Bayer flags major Phase III results for stroke prevention drug asundexian
The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy
The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy
One Health-based surveillance model to focus on bird sanctuaries and high-risk human populations
ICMR-led consultation calls for stricter HFSS regulations, nutrition literacy, and healthier food environments
he innovation could pave the way for early and low-cost screening of smoking exposure and second-hand smoke biomarkers
Outlines nine priority health tracks spanning TB research, digital health, early warning systems and regulatory cooperation
Through the partnership, she plans to share her experience—from consultation through recovery—across her social media platforms
The ninth edition of the event brought together over 800 delegates, more than 60 national and international speakers, and 20+ partner organisations across 10 sessions
At launch of updated pediatric gastroenterology textbook, Union Minister says technology must strengthen not substitute core medical learning
API-first, DPI-driven DDRS platform aims to modernize drug and medical device regulation in India
Move amid evidence of widespread reporting gaps
Subscribe To Our Newsletter & Stay Updated